Brokers see bright future ahead of Polfa and its shareholders

Following the withdrawal of Enterprise Investors (EI) from pharmaceutical producer Polfa Kutno, the latter's liquidity should attracts big investors. There have been many cases where after funds from the EI group decide to sell a given company the price of its shares increased dynamically on the Warsaw Stock Exchange. According to analysts, such a scenario will also repeat in the case of Polfa, although on a slightly smaller scale. Several days ago EI sold around 68% of Polfa's capital at zł. 235 per share. "In my opinion, the value of the shares will exceed zł. 300 this year," said Hanna Kędziora, an analyst from BRE Bank Investment House. "After Polfa's takeover the funds changed the management and came up with a new effective strategy. Currently, the drugs producer's sales are already increasing and it is gearing up to launch new products," she added. (Puls Biznesu, p. 8) A.Z.